Update on Pharmacologic Approaches to Prevent Thromboembolism in Atrial Fibrillation: Are Thrombin and Factor Xa Inhibitors the Ultimate Answer?

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|9|3|350-357

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.9, Iss.3, 2011-05, pp. : 350-357

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Pharmacologic Approaches to Prevent Thromboembolism in Patients with Atrial Fibrillation

By  

Current Vascular Pharmacology, Vol. 5, Iss. 3, 2007-07 ,pp. : 211-219

Bentham Science Publishers

Access to resources Recommend Favorite

Atrial Fibrillation in Patients Undergoing Surgical Revascularization: An Update on Pharmacologic Prophylaxis

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 10, Iss. 4, 2012-12 ,pp. : 325-338

Bentham Science Publishers

Access to resources Recommend Favorite

Factor Xa Inhibitors in Acute Coronary Syndromes and Venous Thromboembolism

By  

Current Vascular Pharmacology, Vol. 8, Iss. 1, 2010-01 ,pp. : 5-11

Bentham Science Publishers

Access to resources Recommend Favorite

Synthetic Inhibitors of Thrombin and Factor Xa - What tests and if so why?

By Hauptmann J.   Sturzebecher J.  

Thrombosis Research, Vol. 93, Iss. 5, 1999-03 ,pp. : 203-241

Elsevier

Access to resources Recommend Favorite

Novel Antithrombotic Agents: Indirect Synthetic Inhibitors of Factor Xa and Direct Thrombin Inhibitors. Evidences from Clinical Studies

By  

Current Medicinal Chemistry - Cardiovascular & Hematological Agents, Vol. 2, Iss. 4, 2004-10 ,pp. : 311-326

Bentham Science Publishers

Access to resources Recommend Favorite